Place: Japan
| Development No. Generic name |
Therapeutic Category | Dosage form | Stage |
|---|---|---|---|
| T-4288 | Fluoroketolide antibiotic (Otorhinolaryngology infectious disease) |
Oral | NDA filing |
| T-4288 | Fluoroketolide antibiotic (Respiratory infectious disease) |
Oral | Phase 3 |
| Favipiravir | Anti-SFTS (serious fever with thrombocytopenia syndrome) virus agent | Oral | NDA filing |
* T-817MA：Deleted from the pipeline due to development termination.
(As of Feb. 2024)
FUJIFILM Toyama Chemical Co., Ltd. has following patent rights.
Acts of making, selling or offering to sell these compounds infringe the following patent rights of FUJIFILM Toyama Chemical Co., Ltd. without the permission of FUJIFILM Toyama Chemical Co., Ltd.
Please make sure not to infringe the patent rights of FUJIFILM Toyama Chemical Co., Ltd.
- Favipiravir
Japanese patent No. 3453362
- Garenoxacin
Japanese patent No. 3281872